STERIS plc Selling, General and Administrative Expense
STERIS plc (STE) reported Selling, General and Administrative Expense of $369.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-07
- STERIS plc selling, general and administrative expense for the quarter ending 2026-06-30 was $369.70M, a 4.49% increase year-over-year.
- STERIS plc selling, general and administrative expense for the quarter ending 2026-03-31 was $351.80M, a 5.36% increase year-over-year.
- STERIS plc selling, general and administrative expense for the quarter ending 2025-12-31 was $352.30M, a 5.01% increase year-over-year.
- STERIS plc selling, general and administrative expense for the quarter ending 2025-09-30 was $349.70M, a 6.19% increase year-over-year.
- STERIS plc selling, general and administrative expense for fiscal 2026 was $1.41B, a 5.50% increase from fiscal 2025.
- STERIS plc selling, general and administrative expense for fiscal 2025 was $1.33B, a 6.55% increase from fiscal 2024.
- STERIS plc selling, general and administrative expense for fiscal 2024 was $1.25B, a 14.82% increase from fiscal 2023.
- STERIS plc selling, general and administrative expense for fiscal 2023 was $1.09B, a 17.28% decline from fiscal 2022.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $369.70M 10-Q · filed 2026-08-07 | $721.50M derived: sum of 2 quarters · filed 2026-08-07 | $1.07B derived: sum of 3 quarters · filed 2026-08-07 | $1.42B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $351.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $704.10M derived: sum of 2 quarters · filed 2026-05-29 | $1.05B derived: sum of 3 quarters · filed 2026-05-29 | $1.41B 10-K · filed 2026-05-29 | ||||
| 2025-12-31 | $352.30M 10-Q · filed 2026-02-06 | $702.00M derived: sum of 2 quarters · filed 2026-02-06 | $1.06B 10-Q · filed 2026-02-06 | $1.39B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-09-30 | $349.70M 10-Q · filed 2025-11-06 | $703.60M 10-Q · filed 2025-11-06 | $1.04B derived: sum of 3 quarters · filed 2026-08-07 | $1.37B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $353.80M 10-Q · filed 2026-08-07 | $687.70M derived: sum of 2 quarters · filed 2026-08-07 | $1.02B derived: sum of 3 quarters · filed 2026-08-07 | $1.35B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $333.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $669.40M derived: sum of 2 quarters · filed 2026-05-29 | $998.70M derived: sum of 3 quarters · filed 2026-05-29 | $1.33B 10-K · filed 2026-05-29 | $1.33B 10-K · filed 2025-05-29 | |||
| 2024-12-31 | $335.50M 10-Q · filed 2026-02-06 | $335.45M 10-Q · filed 2025-02-07 | $664.80M derived: sum of 2 quarters · filed 2026-02-06 | $1.00B 10-Q · filed 2026-02-06 | $1.00B 10-Q · filed 2025-02-07 | $1.31B derived: sum of 4 quarters · filed 2026-05-29 | ||
| 2024-09-30 | $329.30M 10-Q · filed 2025-11-06 | $329.30M 10-Q · filed 2024-11-07 | $664.90M 10-Q · filed 2025-11-06 | $664.92M 10-Q · filed 2024-11-07 | $973.95M derived: sum of 3 quarters · filed 2026-05-29 | $1.28B derived: sum of 4 quarters · filed 2026-05-29 | ||
| 2024-06-30 | $335.60M 10-Q · filed 2025-08-07 | $335.63M 10-Q · filed 2024-08-08 | $644.64M derived: sum of 2 quarters · filed 2026-05-29 | $952.94M derived: sum of 3 quarters · filed 2026-05-29 | $1.28B derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-03-31 | $309.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $617.34M derived: sum of 2 quarters · filed 2026-05-29 | $945.77M derived: sum of 3 quarters · filed 2026-05-29 | $1.25B 10-K · filed 2026-05-29 | $1.25B 10-K · filed 2024-05-29 | |||
| 2023-12-31 | $308.30M 10-Q · filed 2025-02-07 | $360.52M 10-Q · filed 2024-02-08 | $636.73M derived: sum of 2 quarters · filed 2025-02-07 | $943.25M 10-Q · filed 2025-02-07 | $1.10B 10-Q · filed 2024-02-08 | $1.07B derived: sum of 4 quarters · filed 2025-05-29 | ||
| 2023-09-30 | $328.43M 10-Q · filed 2024-11-07 | $380.65M 10-Q · filed 2023-11-07 | $634.96M 10-Q · filed 2024-11-07 | $739.71M 10-Q · filed 2023-11-07 | $762.66M derived: sum of 3 quarters · filed 2025-05-29 | $1.07B derived: sum of 4 quarters · filed 2025-05-29 | ||
| 2023-06-30 | $306.53M 10-Q · filed 2024-08-08 | $359.06M 10-Q · filed 2023-08-08 | $434.23M derived: sum of 2 quarters · filed 2025-05-29 | $739.37M derived: sum of 3 quarters · filed 2025-05-29 | $1.06B derived: sum of 4 quarters · filed 2025-05-29 | |||
| 2023-03-31 | $127.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $432.84M derived: sum of 2 quarters · filed 2025-05-29 | $756.04M derived: sum of 3 quarters · filed 2025-05-29 | $1.09B 10-K · filed 2025-05-29 | $1.30B 10-K · filed 2023-05-26 | |||
| 2022-12-31 | $305.14M 10-Q · filed 2024-02-08 | $628.34M derived: sum of 2 quarters · filed 2024-02-08 | $962.96M 10-Q · filed 2024-02-08 | $1.23B derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-09-30 | $323.19M 10-Q · filed 2023-11-07 | $657.82M 10-Q · filed 2023-11-07 | $927.19M derived: sum of 3 quarters · filed 2024-05-29 | $1.24B derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-06-30 | $334.63M 10-Q · filed 2023-08-08 | $603.99M derived: sum of 2 quarters · filed 2024-05-29 | $914.55M derived: sum of 3 quarters · filed 2024-05-29 | $1.26B derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-03-31 | $269.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | $579.93M derived: sum of 2 quarters · filed 2024-05-29 | $924.73M derived: sum of 3 quarters · filed 2024-05-29 | $1.32B 10-K · filed 2024-05-29 | $1.50B 10-K · filed 2022-05-31 | |||
| 2021-12-31 | $310.56M 10-Q · filed 2023-02-08 | $655.36M derived: sum of 2 quarters · filed 2023-02-08 | $1.05B 10-Q · filed 2023-02-08 | $1.27B derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-09-30 | $344.80M 10-Q · filed 2022-11-09 | $738.55M 10-Q · filed 2022-11-09 | $959.62M derived: sum of 3 quarters · filed 2023-05-26 | $1.14B derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-06-30 | $393.75M 10-Q · filed 2022-08-08 | $614.82M derived: sum of 2 quarters · filed 2023-05-26 | $797.20M derived: sum of 3 quarters · filed 2023-05-26 | $969.90M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-03-31 | $221.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $403.44M derived: sum of 2 quarters · filed 2023-05-26 | $576.15M derived: sum of 3 quarters · filed 2023-05-26 | $731.32M 10-K · filed 2023-05-26 | ||||
| 2020-12-31 | $182.37M 10-Q · filed 2022-02-09 | $355.08M derived: sum of 2 quarters · filed 2022-02-09 | $510.25M 10-Q · filed 2022-02-09 | $699.31M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-09-30 | $172.71M 10-Q · filed 2021-11-08 | $327.88M 10-Q · filed 2021-11-08 | $327.88M 10-Q · filed 2020-11-06 | $516.94M derived: sum of 3 quarters · filed 2022-05-31 | $689.87M derived: sum of 4 quarters · filed 2022-05-31 | |||
| 2020-06-30 | $155.17M 10-Q · filed 2021-08-09 | $344.23M derived: sum of 2 quarters · filed 2022-05-31 | $517.16M derived: sum of 3 quarters · filed 2022-05-31 | $693.12M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-03-31 | $189.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | $361.99M derived: sum of 2 quarters · filed 2022-05-31 | $537.95M derived: sum of 3 quarters · filed 2022-05-31 | $716.73M 10-K · filed 2022-05-31 | ||||
| 2019-12-31 | $172.93M 10-Q · filed 2021-02-09 | $348.89M derived: sum of 2 quarters · filed 2021-02-09 | $527.67M 10-Q · filed 2021-02-09 | $700.79M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-09-30 | $175.96M 10-Q · filed 2020-11-06 | $354.74M 10-Q · filed 2020-11-06 | $527.86M derived: sum of 3 quarters · filed 2021-05-28 | $703.96M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-06-30 | $178.78M 10-Q · filed 2020-08-07 | $351.90M derived: sum of 2 quarters · filed 2021-05-28 | $528.00M derived: sum of 3 quarters · filed 2021-05-28 | $690.31M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-03-31 | $173.12M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28 | $349.22M derived: sum of 2 quarters · filed 2021-05-28 | $511.53M derived: sum of 3 quarters · filed 2021-05-28 | $669.94M 10-K · filed 2021-05-28 | ||||
| 2018-12-31 | $176.10M 10-Q · filed 2020-02-10 | $338.41M derived: sum of 2 quarters · filed 2020-02-10 | $496.82M 10-Q · filed 2020-02-10 | |||||
| 2018-09-30 | $162.31M 10-Q · filed 2019-11-07 | $320.72M 10-Q · filed 2019-11-07 | ||||||
| 2018-06-30 | $158.41M 10-Q · filed 2019-08-07 | |||||||
| 2018-03-31 | $631.98M 8-K · filed 2021-02-09 | |||||||
| 2017-03-31 | $682.04M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |